Bekir Yukcu

Dr. Bekir Yukcu

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2024 in Medicine
Verified
Journal Article
Open access
BYBekir Yukcu
Bekir Yukcu
HAHilmi Furkan Arslan
Hilmi Furkan Arslan
Systemic inflammatory indices, originally developed to predict the prognosis of cancer patients, have found increasing application in various medical areas, including cardiovascular research. This study aimed to investigate the relationship between ascending aortic dilatation in bicuspid aortic valve patients and systemic inflammatory indices. This retrospective cross-sectional study included 122 patients with bicuspid aortic valves. These patients were divided into 2 groups based on the presence or absence of dilatation according to ascending aorta z-scores. Complete blood counts were analyzed, focusing on leukocyte, neutrophil, lymphocyte, monocyte, and platelet counts. Additionally, systemic inflammatory indices including neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio (PLR), Systemic Immune-Inflammation Index (SII), Systemic Inflammatory Response Index (SIRI), and monocyte-to-lymphocyte ratio (MLR) and pan-immune-inflammation value (PIV) were calculated from these parameters. MLR, SIRI, and PIV demonstrated acceptable diagnostic power in detecting ascending aortic dilatation in bicuspid aortic valve patients, with area under the curve (AUC) values of 0.709, 0.741, and 0.779, respectively. PLR and SII exhibited fair diagnostic power, with AUC values of 0.673 and 0.688, respectively. According to the receiver operating characteristic analysis, PIV had the highest AUC value of 0.779 (95% confidence interval [CI] = 0.69–0.86), with a sensitivity of 70.9% and specificity of 70.8% at a cutoff value of 224.93. A relationship exists between PLR, MLR, SII, SIRI, PIV, and ascending aorta dilatation in pediatric patients with bicuspid aortic valves. These findings suggest that inflammation may play a role in the dilatation of the ascending aorta in bicuspid aortic valve patients.

1 January 2025 in SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
Verified
Journal Article
Open access
BYBekir Yukcu
Bekir Yukcu
This study aimed to evaluate the etiology, clinical characteristics, and outcomes of mesenteric lymphadenopathy (ML) in children, with an emphasis on its clinical significance and management strategies. This cross-sectional, single-center study was conducted between July 2016 and May 2017 and included pediatric patients aged 1 month to 18 years diagnosed with ML via abdominal ultrasonography. Patients with malignancies, acute infections, ongoing corticosteroid or antibiotic treatment, or incomplete follow-up were excluded. Data collection included demographic, clinical, and laboratory findings. Statistical analyses were performed using IBM SPSS Statistics version 25. The Mann–Whitney U test was used for comparisons of numerical variables between groups, while the chi-square and Fisher’s exact tests were applied for categorical variables. A p-value less than 0.05 was considered statistically significant. A total of 106 patients were included with a median age of 7.4 years (range: 8 months–16.4 years), of whom 55.7% were male. The majority (63%) were aged 6–11 years. Abdominal pain was the most common symptom (64.2%), and 99.1% of the ML cases were localized in the right lower quadrant. At 1-month follow-up, lymph node sizes regressed to normal in 71.7% of cases, while 28.3% remained pathological. Antibiotic use did not significantly affect lymph node regression. At 6 months, no new symptoms or diagnoses were reported in the 91 patients contacted. ML was most often idiopathic (76.4%), with secondary causes including gastrointestinal and respiratory infections, acute abdomen, and Familial Mediterranean Fever. In children, ML is predominantly benign and self-limiting, and in most cases, it resolves without medical intervention. Although its association with symptoms such as abdominal pain may cause anxiety in parents, careful monitoring of patients can prevent unnecessary interventions. This study underscored the importance of conservative management and highlighted the need for further research with larger cohorts and extended follow-up periods to explore rare etiologies and long-term outcomes.

31 December 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BYBekir Yukcu
Bekir Yukcu
MAMerve Maze Aydemir
Merve Maze Aydemir
MBMEHMET BALCI
MEHMET BALCI
MKMehmet Kanyilmaz
Mehmet Kanyilmaz
ATAysel Türkvatan
Aysel Türkvatan
SASezen UGAN ATİK
Sezen UGAN ATİK
Objectives: Cardiac magnetic resonance (CMR) plays a central role in the diagnosis and follow-up of acute myocarditis (AM). In this study, we aimed to evaluate baseline and follow-up CMR findings and associated factors in children with AM. Methods: A retrospective analysis of CMR in pediatric patients with clinical presentations suggestive of myocarditis was performed. Patients’ demographic characteristics, clinical data, and diagnostic test results, as well as CMR imaging results, were evaluated. Results: All 28 pediatric patients with acute myocarditis included in this study had late gadolinium enhancement (LGE) on initial CMR imaging. Additionally, 14 (50%) patients had increased extracellular volume (ECV), 4 (50%) patients had focal high-intensity areas on T2 STIR images, 15 (53.6%) patients had increased T1 relaxation time, and 17 (60.7%) patients had increased T2 relaxation time. At a median follow-up CMR of 6 months, 24 (85.7%) patients had LGE, 5 (17.9%) patients had increased ECV, and 7 (25%) patients had increased T1 relaxation time, while other parameters showed complete recovery. Baseline troponin and CRP levels, T1 relaxation time, T2 relaxation time, and increased ECV were found to be factors associated with the resolution of LGE. Conclusions: Baseline troponin and CRP levels, as well as T1 relaxation time, T2 relaxation time, and increased ECV, were effective parameters that seemed to predict the resolution of LGE. Larger and multicenter experiences would confirm these hypotheses.

24 January 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
MAMehmet Albayrak
Mehmet Albayrak
BYBekir Yukcu
Bekir Yukcu
Objective: This study investigated the impact of maternal subclinical hypothyroidism on fetal thymus size and development and explored how inadequate thyroid hormone production in pregnant women affects the fetal thymus. Methods: Conducted at the Giresun Obstetrics, Gynecology, and Pediatrics Training and Research Hospital, this case–control study involved 86 pregnant women, 43 with hypothyroidism and 43 without. Maternal thyroid function was assessed using TSH and free T4 levels, and fetal thymus size and thymus–thorax ratio were measured using ultrasound. Exclusion criteria were chronic hypertension, gestational hypertension or eclampsia, multiple pregnancies, infectious diseases, renovascular diseases, diagnosed with hypothyroidism prior to pregnancy and other endocrine disorders, fetal cardiac diseases, and morbid obesity. Data collected included maternal age, gestational week, number of pregnancies, parity, number of living children, thyroid-stimulating hormone (TSH) and Free thyroxine 4 (T4) levels, and fetal thymus measurements (transverse diameter and thymus/thorax ratio). Statistical analyses were performed using the Mann–Whitney U test and logistic regression analysis. The relationships between TSH, thymus diameters, thorax diameters, and the thymus–thorax ratio were evaluated using Spearman’s correlation coefficient. Results: The thymus–thorax ratio was significantly reduced in the hypothyroid group (p = 0.003). Logistic regression analysis identified TSH as an independent risk factor for a low thymus–thorax ratio, with each unit increase in TSH associated with a 1.345-fold higher likelihood of having a low thymus–thorax ratio. A significant negative correlation was found between TSH levels and the TTR ratio (Spearman’s correlation coefficient r = −0.338, p = 0.001). Conclusions: An association was identified between maternal TSH levels and the thymus–thorax ratio, with increasing TSH levels correlating with a decrease in the thymus–thorax ratio. Regular monitoring of thyroid hormone levels during pregnancy and appropriate replacement treatment in cases of deficiency are crucial for optimal fetal thymus development. Further multicenter studies are needed to confirm these findings and investigate the long-term implications of altered fetal thymus development.

30 June 2025 in TURKISH JOURNAL of CLINICS and LABORATORY
Verified
Journal Article
Open access
PDF file
BYBekir Yukcu
Bekir Yukcu
MAMehmet Albayrak
Mehmet Albayrak
Aim: This study aimed to investigate the association between second-trimester maternal hypothyroidism and congenital heart diseases (CHDs) in fetuses. Material and Methods: This retrospective study was conducted at Obstetrics and Pediatrics Training and Research Hospital between June 2022 and December 2024. The patient group comprised mothers of children diagnosed with major CHDs, while the control group included mothers of children without CHDs or with minor anomalies not requiring intervention. Maternal thyroid status was determined by second-trimester TSH levels: >4.0 mIU/mL was classified as hypothyroid, while 0.2–4.0 mIU/mL was considered euthyroid. Statistical analyses, including ROC analysis, regression analysis, Chi-square test, Fisher's exact test, and Mann-Whitney U test, were performed using SPSS 25, with p < 0.05 considered significant. Results: The median TSH level was significantly higher in the CHD group compared to controls (p = 0.002). Logistic regression analysis revealed that each unit increase in maternal TSH levels increased the risk of fetal CHD by 1.47 times (95% CI: 1.212–1.792, p < 0.001). ROC analysis determined an optimal TSH cutoff of 1.795 mIU/mL (AUC = 0.627; sensitivity: 59.6%, specificity: 59.4%). While differences in CHD subgroups were observed, including conotruncal and valvular defects, these did not reach statistical significance (p > 0.05). Conclusion: The study suggests a potential association between maternal hypothyroidism and fetal CHD.

1 January 2025 in Turkish Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Open access
EDEnsar Duras
Ensar Duras
ECErman Cilsal
Erman Cilsal
SGSelman Gokalp
Selman Gokalp
SASezen UGAN ATİK
Sezen UGAN ATİK
MŞMurat Şahin
Murat Şahin
AGAlper Güzeltaş
Alper Güzeltaş
Background: This study aimed to assess the outcomes of valve-in-valve implantation within previously placed bioprosthetic valves. Methods: This single-center retrospective study included patients who underwent percutaneous valve-in-valve procedures between July 2014 and September 2023. These patients had previously received pulmonary bioprosthetic valves via surgical or transcatheter methods. Results: The study included 20 patients (13 males, 7 females; mean age: 20.4±7.1 years; range, 10.8 to 35.8 years). Preprocedural assessment revealed stenotic dysfunction in 12 patients, regurgitant dysfunction in two patients, and a combination of both in six patients. Following implantation, there was a notable improvement in invasive measurements; systolic right ventricular pressure decreased from 64.0±24.5 mmHg to 31.3±6.7 mmHg (p<0.001), right ventricular outflow tract gradient from 44.0±23.2 mmHg to 7.6±5.8 mmHg (p<0.001), and echocardiographic pulmonary regurgitation grade from 2.1±1.2 to 0.2±0.4 (p<0.001). The median time between initial bioprosthetic pulmonary valve placement and valve-in-valve procedure was 8.2 years (IQR, 6.2 to 9.9 years). The median follow-up duration was 24.8 months (IQR, 8.3 to 40.2 months). Only one patient required a repeat PPVI procedure 10 years after the valve-in-valve procedure, while no other patients required reintervention during the follow-up period. Conclusion: Valve-in-valve implantation within previously placed bioprosthetic valves is a feasible and safe approach, offering symptom relief and eliminating the need for further surgical interventions.